Neuropathological heterogeneity in Alzheimer's disease: A study of 80 cases using principal components analysis

被引:41
|
作者
Armstrong, RA
Nochlin, D
Bird, TD
机构
[1] Aston Univ, Birmingham B4 7ET, W Midlands, England
[2] Univ Washington, Hlth Sci Ctr, Dept Pathol Neuropathol Lab, Seattle, WA 98195 USA
[3] Vet Adm Med Ctr, Seattle, WA 98195 USA
关键词
Alzheimer's disease; apolipoprotein E; neurodegeneration; neurofibrillary tangles; principal components analysis; senile plaques;
D O I
10.1046/j.1440-1789.2000.00284.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Three hypotheses have been proposed to explain neuropathological heterogeneity in Alzheimer's disease (AD): the presence of distinct subtypes ('subtype hypothesis'), variation in the stage of the disease ('phase hypothesis') and variation in the origin and progression of the disease ('compensation hypothesis'). To test these hypotheses, variation in the distribution and severity of senile plaques (SP) and neurofibrillary tangles (NFT) was studied in 80 cases of AD using principal components analysis (PCA). Principal components analysis using the cases as variables (Q-type analysis) suggested that individual differences between patients were continuously distributed rather than the cases being clustered into distinct subtypes. In addition, PCA using the abundances of SP and NFT as variables (R-type analysis) suggested that variations in the presence and abundance of lesions in the frontal and occipital lobes, the cingulate gyrus and the posterior parahippocampal gyrus were the most important sources of heterogeneity consistent with the presence of different stages of the disease. In addition, in a subgroup of patients, individual differences were related to apolipoprotein E (ApoE) genotype, the presence and severity of SP in the frontal and occipital cortex being significantly increased in patients expressing apolipoprotein (Apo)E allele epsilon 4. It was concluded that some of the neuropathological heterogeneity in our AD cases may be consistent with the 'phase hypothesis'. A major factor determining this variation in late-onset cases was ApoE genotype with accelerated rates of spread of the pathology in patients expressing allele epsilon 4.
引用
收藏
页码:31 / 37
页数:7
相关论文
共 50 条
  • [1] Neuropathological heterogeneity in frontotemporal lobar degeneration with TDP-43 proteinopathy: a quantitative study of 94 cases using principal components analysis
    Richard A. Armstrong
    William Ellis
    Ronald L. Hamilton
    Ian R. A. Mackenzie
    John Hedreen
    Marla Gearing
    Thomas Montine
    Jean-Paul Vonsattel
    Elizabeth Head
    Andrew P. Lieberman
    Nigel J. Cairns
    [J]. Journal of Neural Transmission, 2010, 117 : 227 - 239
  • [2] Neuropathological heterogeneity in frontotemporal lobar degeneration with TDP-43 proteinopathy: a quantitative study of 94 cases using principal components analysis
    Armstrong, Richard A.
    Ellis, William
    Hamilton, Ronald L.
    Mackenzie, Ian R. A.
    Hedreen, John
    Gearing, Marla
    Montine, Thomas
    Vonsattel, Jean-Paul
    Head, Elizabeth
    Lieberman, Andrew P.
    Cairns, Nigel J.
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2010, 117 (02) : 227 - 239
  • [3] Disease progression modelling of Alzheimer's disease using probabilistic principal components analysis
    Saint-Jalmes, Martin
    Fedyashov, Victor
    Beck, Daniel
    Baldwin, Timothy
    Faux, Noel G.
    Bourgeat, Pierrick
    Fripp, Jurgen
    Masters, Colin L.
    Goudey, Benjamin
    [J]. NEUROIMAGE, 2023, 278
  • [4] Principal components analysis of agitation outcomes in Alzheimer's disease
    Yesavage, Jerome A.
    Taylor, Joy L.
    Friedman, Leah
    Rosenberg, Paul B.
    Lazzeroni, Laura C.
    Leoutsakos, Jeannie-Marie S.
    Kinoshita, Lisa M.
    Perlow, Mark J.
    Munro, Cynthia A.
    Devanand, D. P.
    Drye, Lea T.
    Mintzer, Jacobo E.
    Pollock, Bruce G.
    Porsteinsson, Anton P.
    Schneider, Lon S.
    Shade, David M.
    Weintraub, Daniel
    Lyketsos, Constantine G.
    Noda, Art
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 2016, 79 : 4 - 7
  • [5] Principal components analysis of the neuropsychiatric inventory in Alzheimer's disease
    Hollingworth, P
    Hamshere, ML
    Hill, GT
    Moore, PJ
    Ludford, RM
    Foy, C
    Archer, N
    Edmondson, A
    Proitsi, P
    Lynch, A
    Evans, I
    Hamilton, BA
    Lovestone, S
    Powell, J
    Brayne, C
    Rubinsztein, DC
    Lawlor, B
    Gill, M
    Owen, MJ
    [J]. NEUROBIOLOGY OF AGING, 2004, 25 : S97 - S97
  • [6] Is neuropathological heterogeneity in Alzheimer's disease related to apolipoprotein genotype?
    Armstrong, RA
    Wade, KM
    Nochlin, D
    Bird, TD
    [J]. ALZHEIMERS REPORTS, 1998, 1 (04): : 217 - 221
  • [7] What is 'Alzheimer's disease'? The neuropathological heterogeneity of clinically defined Alzheimer's dementia
    Mehta, Rupal I.
    Schneider, Julie A.
    [J]. CURRENT OPINION IN NEUROLOGY, 2021, 34 (02) : 237 - 245
  • [8] Neuropathological changes in ten cases of neuronal intermediate filament inclusion disease (NIFID): a study using α-internexin immunohistochemistry and principal components analysis (PCA)
    R. A. Armstrong
    E. Kerty
    K. Skullerud
    N. J. Cairns
    [J]. Journal of Neural Transmission, 2006, 113 : 1207 - 1215
  • [9] Neuropathological changes in ten cases of neuronal intermediate filament inclusion disease (NIFID):: a study using α-internexin immunohistochemistry and principal components analysis (PCA)
    Armstrong, R. A.
    Kerty, E.
    Skullerud, K.
    Cairns, N. J.
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2006, 113 (09) : 1207 - 1215
  • [10] β-amyloid (Aβ) deposition in cognitively normal brain, dementia with Lewy bodies, and Alzheimer's disease: a study using principal components analysis
    Armstrong, Richard A.
    [J]. FOLIA NEUROPATHOLOGICA, 2012, 50 (02) : 130 - 139